AU574246B2 - Homodisaccharide hypoglycemic agents - Google Patents

Homodisaccharide hypoglycemic agents

Info

Publication number
AU574246B2
AU574246B2 AU50810/85A AU5081085A AU574246B2 AU 574246 B2 AU574246 B2 AU 574246B2 AU 50810/85 A AU50810/85 A AU 50810/85A AU 5081085 A AU5081085 A AU 5081085A AU 574246 B2 AU574246 B2 AU 574246B2
Authority
AU
Australia
Prior art keywords
homodisaccharide
hypoglycemic agents
homonojirimycin
protected
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU50810/85A
Other languages
English (en)
Other versions
AU5081085A (en
Inventor
Paul S. Liu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Publication of AU5081085A publication Critical patent/AU5081085A/en
Application granted granted Critical
Publication of AU574246B2 publication Critical patent/AU574246B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Luminescent Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU50810/85A 1984-12-18 1985-12-05 Homodisaccharide hypoglycemic agents Ceased AU574246B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US683127 1984-12-18
US06/683,127 US4634765A (en) 1984-12-18 1984-12-18 Homodisaccharide hypoglycemic agents

Publications (2)

Publication Number Publication Date
AU5081085A AU5081085A (en) 1986-06-26
AU574246B2 true AU574246B2 (en) 1988-06-30

Family

ID=24742682

Family Applications (1)

Application Number Title Priority Date Filing Date
AU50810/85A Ceased AU574246B2 (en) 1984-12-18 1985-12-05 Homodisaccharide hypoglycemic agents

Country Status (20)

Country Link
US (1) US4634765A (OSRAM)
EP (1) EP0186103B1 (OSRAM)
JP (1) JPS61158994A (OSRAM)
KR (1) KR900005607B1 (OSRAM)
CN (1) CN1016784B (OSRAM)
AT (1) ATE62249T1 (OSRAM)
AU (1) AU574246B2 (OSRAM)
CA (1) CA1240989A (OSRAM)
DE (1) DE3582420D1 (OSRAM)
DK (1) DK587085A (OSRAM)
ES (1) ES8706164A1 (OSRAM)
FI (1) FI80707C (OSRAM)
GR (1) GR853032B (OSRAM)
HU (1) HU194263B (OSRAM)
IE (1) IE58186B1 (OSRAM)
NO (1) NO162387B (OSRAM)
NZ (1) NZ214570A (OSRAM)
PH (1) PH23660A (OSRAM)
PT (1) PT81689B (OSRAM)
ZA (1) ZA859573B (OSRAM)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2181729B (en) * 1985-10-12 1990-04-04 Nippon Shinyaku Co Ltd Glucosylmoranoline derivatives and production thereof
JPS62242692A (ja) * 1986-04-15 1987-10-23 Nippon Shinyaku Co Ltd モラノリン誘導体の製造法
EP0344383A1 (en) * 1988-06-02 1989-12-06 Merrell Dow Pharmaceuticals Inc. Novel alpha-Glucosidase inhibitors
EP0345104B1 (en) * 1988-06-02 1995-11-02 Merrell Dow Pharmaceuticals Inc. Novel Alpha-glucosidase inhibitors
US4880917A (en) * 1988-07-01 1989-11-14 Merrell Dow Pharmaceuticals Inc. Process for hydrolyzing 2,6-dideoxy-2,6-iminoheptononitrile derivatives using trifluoroacetic acid and dinitrogen tetroxide
US4908439A (en) * 1988-09-16 1990-03-13 Merrell Dow Pharmaceuticals Inc. Synthesis of intermediate useful in the preparation of nojirimycin and related compounds
US5227479A (en) * 1989-12-20 1993-07-13 Merrell Dow Pharmaceuticals Inc. Process for the preparation of nojirimycin and related compounds
US5504078A (en) * 1990-06-08 1996-04-02 Merrell Dow Pharmaceuticals Inc. α-glucosidase inhibitors
ATE422359T1 (de) * 1997-04-15 2009-02-15 Csir Verbindungen und pharmazeutische zusammensetzungen mit appetitunterdrückender aktivität
GB2396815B (en) * 1999-10-27 2004-09-08 Phytopharm Plc A composition comprising a pregnenone derivative and an NSAID
EP1181277A4 (en) 2000-03-31 2005-08-10 Univ Michigan State PROCESS FOR THE PREPARATION OF 1,5-DIDESOXY-1,5-IMINO HEXITOLS FROM OXIMES OR IMINES
GB2363985B (en) 2000-06-30 2004-09-29 Phytopharm Plc Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use
US7262318B2 (en) * 2004-03-10 2007-08-28 Pfizer, Inc. Substituted heteroaryl- and phenylsulfamoyl compounds
US20050288340A1 (en) * 2004-06-29 2005-12-29 Pfizer Inc Substituted heteroaryl- and phenylsulfamoyl compounds
AU2005308575A1 (en) * 2004-11-23 2006-06-01 Warner-Lambert Company Llc 7-(2h-pyrazol-3-yl)-3, 5-dihyroxy-heptanoic acid derivatives as HMG Co-A reductase inhibitors for the treatment of lipidemia
WO2006133447A1 (en) * 2005-06-08 2006-12-14 Amicus Therapeutics, Inc. Crystalline sugar compositions and method of making
US20060293508A1 (en) * 2005-06-08 2006-12-28 Michael Major Stabilization of triflated compounds
US7973157B2 (en) * 2005-06-08 2011-07-05 Amicus Therapeutics, Inc. Imino and amino sugar purification
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
JP5498168B2 (ja) 2006-12-01 2014-05-21 ブリストル−マイヤーズ スクイブ カンパニー アテローム性動脈硬化および循環器疾患の治療のためのｃｅｔｐ阻害剤としてのｎ−（（３−ベンジル）−２，２−（ビス−フェニル）−プロパン−１−アミン誘導体
ATE518544T1 (de) 2007-03-12 2011-08-15 Zadec Aps Rotbusch-extrakt gegen diabetes
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
MX2009013293A (es) 2007-06-04 2010-02-15 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos.
EP2810951B1 (en) 2008-06-04 2017-03-15 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
CA2730603C (en) 2008-07-16 2019-09-24 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
CA2799708A1 (en) 2010-05-21 2011-11-24 Pfizer Inc. 2-phenyl benzoylamides
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CN102462726B (zh) * 2010-11-04 2016-03-09 中国医学科学院药物研究所 白树总生物碱及多羟基生物碱化合物的提取、分离及用途
CA2828343A1 (en) 2011-03-04 2012-09-13 The Scripps Research Institute Edn3-like peptides and uses thereof
US20140323705A1 (en) * 2011-05-13 2014-10-30 Markus Hederos Manufacture of lacto-n-tetraose
MY188344A (en) 2012-03-09 2021-12-01 Biotropics Malaysia Berhad Extract formulations of rhodamnia cinerea and uses thereof
JP2016514671A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼのアゴニストおよびその使用
JP2016514670A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
SG11201507496UA (en) 2013-04-17 2015-11-27 Pfizer N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
EA201592263A1 (ru) 2013-06-05 2016-05-31 Синерджи Фармасьютикалз, Инк. Ультрачистые агонисты гуанилатциклазы c, способ их получения и использования
EP3186242B1 (en) 2014-08-29 2021-10-06 Tes Pharma S.r.l. Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CN104530150A (zh) * 2015-01-14 2015-04-22 佛山市赛维斯医药科技有限公司 含胺基苯和双葡萄糖苷结构化合物、其制备方法和用途
AU2017342083A1 (en) 2016-10-14 2019-04-11 Tes Pharma S.R.L. Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase
IT201700078102A1 (it) 2017-07-11 2019-01-11 Dipharma Francis Srl Sintesi di un azazucchero e suoi intermedi
CN108828121B (zh) * 2018-06-14 2020-06-05 华润三九医药股份有限公司 一种白树药材中α-高野尻霉素的含量检测方法
AR117122A1 (es) 2018-11-20 2021-07-14 Tes Pharma S R L INHIBIDORES DE LA ÁCIDO a-AMINO-b-CARBOXIMUCÓNICO SEMIALDEHÍDO DESCARBOXILASA
US11248001B2 (en) 2019-01-18 2022-02-15 Astrazeneca Ab PCSK9 inhibitors and methods of use thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4065562A (en) * 1975-12-29 1977-12-27 Nippon Shinyaku Co., Ltd. Method and composition for reducing blood glucose levels
US4328233A (en) * 1978-11-06 1982-05-04 Bayer Aktiengesellschaft α-Glucosidase inhibiting 2-hydroxymethyl-3,4,5-trihydroxy-piperidines
US4348402A (en) * 1979-10-19 1982-09-07 Bayer Aktiengesellschaft 2-Hydroxyalkyl-3,4,5-trihydroxy-piperidine compounds, their production and their medicinal use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO154918C (no) * 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
GB2064527B (en) * 1979-12-08 1984-05-02 Nippon Shinyaku Co Ltd Moranoline derivatives and process for preparation thereof
IT1210476B (it) * 1981-05-28 1989-09-14 Erba Farmitalia Antracicline.

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4065562A (en) * 1975-12-29 1977-12-27 Nippon Shinyaku Co., Ltd. Method and composition for reducing blood glucose levels
US4328233A (en) * 1978-11-06 1982-05-04 Bayer Aktiengesellschaft α-Glucosidase inhibiting 2-hydroxymethyl-3,4,5-trihydroxy-piperidines
US4348402A (en) * 1979-10-19 1982-09-07 Bayer Aktiengesellschaft 2-Hydroxyalkyl-3,4,5-trihydroxy-piperidine compounds, their production and their medicinal use

Also Published As

Publication number Publication date
CA1240989A (en) 1988-08-23
PT81689A (en) 1986-01-01
FI854944A0 (fi) 1985-12-13
DK587085A (da) 1986-06-19
KR860004921A (ko) 1986-07-16
FI854944L (fi) 1986-06-19
FI80707B (fi) 1990-03-30
CN85109548A (zh) 1986-07-09
EP0186103A2 (en) 1986-07-02
NZ214570A (en) 1988-03-30
PT81689B (pt) 1987-11-30
NO162387B (no) 1989-09-11
FI80707C (fi) 1990-07-10
JPH0565519B2 (OSRAM) 1993-09-17
ES8706164A1 (es) 1987-06-01
DE3582420D1 (de) 1991-05-08
US4634765A (en) 1987-01-06
PH23660A (en) 1989-09-27
JPS61158994A (ja) 1986-07-18
EP0186103A3 (en) 1988-02-03
CN1016784B (zh) 1992-05-27
AU5081085A (en) 1986-06-26
IE853179L (en) 1986-06-18
NO855087L (no) 1986-06-19
HU194263B (en) 1988-01-28
DK587085D0 (da) 1985-12-17
GR853032B (OSRAM) 1986-04-18
ZA859573B (en) 1986-08-27
ES550060A0 (es) 1987-06-01
KR900005607B1 (ko) 1990-07-31
IE58186B1 (en) 1993-07-28
EP0186103B1 (en) 1991-04-03
ATE62249T1 (de) 1991-04-15
HUT40137A (en) 1986-11-28

Similar Documents

Publication Publication Date Title
AU5081085A (en) Homodisaccharide hypoglycemic agents
AU6911187A (en) Protected enzyme systems
AU575668B2 (en) N - acylpyrrolidine compound
AU573300B2 (en) Sodium hypophosphite modified acryic acid copolymers
AU576280B2 (en) Inhibition of decomposition of hydrogen peroxide systems
AU4825285A (en) Surfactant containing anhydrous drug systems
AU536200B2 (en) Compound having anthelmintic and acaricidal activities
IE810167L (en) Tetrahydropyran-2-ones.
AU574864B2 (en) Multiple solution intravenous system
AU574965B2 (en) Cross talk, echo compensation
AU8115187A (en) Enzymes as agricultural chemical adjuvants
AU574532B2 (en) N,n1 - disubstituted imidazoles useful as hypoglycemic agents
AU545275B2 (en) Protection of substrates from microorganisms
AU563995B2 (en) Hypotriglyceridemically active polysaccharides
EP0345081A3 (en) Enzyme formation suppressing agent
AU4477385A (en) 4h-1,4-benzothiazines as inhibitors/stimulators of enzymatic reactions
WO1988003922A3 (en) Thiophenesulfonamide herbicides
AU6523186A (en) Transfer function generation for active noise cancellation
AU5396790A (en) Chromogenic dibenzoxazepinone enzyme substrates
AU2557084A (en) Production of alpha-amylase inhibitor-tendamistat from streptomyces
AU8315687A (en) Propagation of seedlings
AU513041B2 (en) Hydrolytic enzyme from bromelain
PL239327A1 (en) Method of isolation of polyfungine from the culture of highefficient mutant of streptomyces noursei var. polifungini strain
AU2259788A (en) Method for the isolation of active enzyme(s) from krill tissue
IT8320426A0 (it) Composizione di policarbonato autoestinguente.

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired